Operating Lease, Right-of-Use Asset of Terns Pharmaceuticals, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Terns Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Terns Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $938,000, a 32% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Terns Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $938,000 -$438,000 -32% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $1,037,000 +$820,000 +378% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $1,134,000 +$765,000 +207% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $1,248,000 +$725,000 +139% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $1,376,000 +$705,000 +105% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $217,000 -$539,000 -71% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 $369,000 -$532,000 -59% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $523,000 -$524,000 -50% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $671,000 -$523,000 -44% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $756,000 -$489,000 -39% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $901,000 -$475,000 -35% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $1,047,000 +$1,047,000 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $1,194,000 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $1,245,000 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $1,376,000 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $0 31 Dec 2021 10-K 27 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.